Last updated:

COVID-19 Coronavirus

Support recovery now

In late December 2019, people in Wuhan, China began to get sick with a previously unknown pneumonia, marking the beginning of a new infectious disease, later identified as a new type of coronavirus.

The International Committee on the Taxonomy of Viruses selected the name severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to represent that the new virus is a sister of the original SARS virus. The disease the virus causes was named coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO).

The situation continues to change rapidly. Please follow the weekly situation reports from WHO. Check out the most up-to-date statistics from Johns Hopkins University or Worldometers.

As of May 2022, the whole profile is updated every other week unless there is a major development. The U.S. and worldwide summary sections will be updated weekly.

(Photo credit: U.S. Army National Guard photo by Sgt. Amouris Coss)

Latest Updates

See all

About the numbers

The numbers change quickly and vary depending upon which source you use to track. The following are the latest updates and numbers, as of June 16, 2022, from Worldometers and a variety of other sources:

Worldwide
  • In the June 15 Epidemiological Update, the WHO said: “Globally, the number of new weekly cases has continued to decline since a peak in January 2022. During the week of 6 until 12 June 2022, over 3.2 million cases were reported, similar to the number reported during the previous week. After five weeks of decline, the number of new weekly deaths has risen again, with over 8700 fatalities reported, a 4% increase as compared to the previous week. As of 12 June 2022, over 533 million confirmed cases and over 6.3 million deaths have been reported globally.”
Source: WHO
  • As more people are vaccinated and boosted, the ability to overcome COVID-19 increases significantly. Death and hospitalization rates remain significantly higher among the unvaccinated population: “Millions of vaccinated people have gotten sick from the omicron strain, but the shots served their most important function—preventing severe illness. During the omicron wave, vaccination with a booster reduced the chance of hospitalization and death by more than 90%. Sudden spikes of cases from the fast-moving variant have pressured health systems, but the outlook for the average Covid patient has improved significantly.”
  • The worldwide case total is 542,640,894 with more than 6.34 million deaths and more than 517.95 million recoveries. Over the past seven days, weekly worldwide new cases have decreased (1%) for a weekly total of 3.81 million new cases.
  • There are cases in 228 countries and territories. There are 64 countries with more than 1 million cases, with 29 of those having more than 4 million cases each.
  • The countries with the most cases after the U.S. (which has 87.76 million cases) are India (43.26 million cases), Brazil (31.61 million cases), France (29.98 million cases) and Germany (27.01 million cases).
  • On May 12, North Korea’s state news agency shared that several cases of COVID-19 had been detected, something the government claimed had not happened since the pandemic began. This week North Korea dropped to fifth overall in new COVID-19 cases. Since then, it is 24th overall with 4.56 million cases reported. North Korea has an incredibly weak medical system and testing capacity is extremely limited. Despite this, the country has reported only 73 deaths and says that 4.51 million people have already recovered. In the past seven days, North Korea reported 278,730 million new cases, a 46% decrease from the week before.
  • The U.S. remains in the first spot for countries with the highest number of new cases in the past seven days for the second consecutive week, with almost 694,846 new cases (12% decrease). Taiwan is in second with just over 451,000 new cases/10% decrease, Germany is third with a 54% increase (slightly more than 354,000 cases) and Brazil is fourth with nearly 300,000/16% increase in new cases.
  • The countries with the highest level of deaths over the previous seven days are U.S., Taiwan, Brazil, Russia and Italy.
United States
  • The New York Times said on June 14, “More than 100,000 cases are currently announced each day in the U.S., a figure that has stayed roughly flat for the month of June. Cases are declining in roughly half the states, particularly in the Northeast and Midwest. In the past two weeks, parts of New England have seen cases fall by 50 percent or more. In the South and West, however, cases and hospitalizations are increasing substantially. Daily new infections have more than doubled this month in Wyoming, and in Mississippi cases and hospitalizations have both increased by more than 70 percent. More than 29,000 people are hospitalized nationwide with the coronavirus, a modest increase from the start of the month. Hospitalizations are decreasing in more than a dozen states, but increases in such populous states as California and Florida have led to continued growth at the national level. Fatality data has been volatile in recent weeks because of delays in reporting after Memorial Day. Still, reports of new deaths remain low. Fewer than 350 deaths are being reported each day, down from more than 2,600 a day at the height of the Omicron surge.”
  • United States cases of COVID-19 decreased by 12% (694,846 new cases) over a seven-day period. There is a daily case average of 104,153 new cases (a 3% increase) over 14 days.
  • There were 1,917 new deaths in the U.S. over the past seven days for a 17% decrease compared to the previous seven days. The death daily average is 319, a 14% increase over 14 days.
  • The U.S. has the highest number of total cases, total deaths, new cases and new deaths.
  • The U.S. case total is 87.76 million with more than 1.04 million deaths and more than 83.51 million recoveries. This means about 1% of resolved (confirmed) cases have ended in death
  • According to the New York Times, as of June 15, at least 1 in 4 U.S. residents have been confirmed infected and at least 1 in 329 people in the country have died from COVID-19.
  • As of June 15, an average of 29,858 people were hospitalized with COVID-19, an 8% increase compared to the previous 14 days. There were 3,303 people in ICUs with COVID-19, an 12% increase. You can see ICU rates at hospitals near you here.
Africa
  • Throughout 2022, Africa has gone up and down with new cases. As of June 9, it had increased by 2% with 33,082 new cases reported in the past seven days. The overall change in deaths was a 20% increase with 266 new deaths reported.
  • While Africa’s death total (255,225) is likely an undercount, so is the total number of cases (12.19 million). With little evidence of overflowing hospitals or mass burials – although some excess deaths have been recorded – Africa seems to be escaping the high death tolls of other areas of the world.
  • South Africa led the country in new cases with 12,662 representing 35%. Morocco had the second-highest number of new cases at 3,308, a 110% increase. Because there were no cases reported last week for several countries, huge increases were recorded with the highest being Uganda’s 173,400% increase with 1,734 new cases.
Europe
  • As of June 9, cases in Europe increased 2% for 936,637 new cases. Deaths were down 15% over the past seven days (3,212 new deaths).
  • Over 670,000 of the cases in Europe were in Germany, France, Portugal or Italy.
  • During the past seven days, 20 of 45 European countries saw increases in new cases (a significant increase from 5 two weeks ago), while 26 countries had a decreased death rate (and 12 had no change).
Asia and Middle East
  • Cases seem to be improving in most Asian and Middle Eastern countries. Regionally, there was a 19% decrease in new cases (1.35 million) and a 3% decrease in new deaths (1,718) as of June 9.
  • As mentioned in the worldwide section, North Korea had the highest number of new cases in the world. Taiwan had the second-highest number of new cases in Asia (almost 500,000) – an 11% decrease.
South America
  • In South America, only eight countries saw an increase in the percentage of new cases as of June 9.
  • Brazil had the highest number of new cases by far at 255,760, which is a 20% increase.
  • Overall, there is a 5% increase (364,475) in new cases and an 11% increase (1,137) in deaths.
Oceania
  • Overall, there was a 17% decrease (243,132) in new cases and a 4% decrease (382) in deaths as of June 9.
  • Australia was the highest in the region with 197,927 new cases for a 17% decrease.
North America (including Central America and the Caribbean)
  • As of June 9, North America as a whole had 814,699 new cases (an increase of 0.1%) with U.S. cases making up more than 729,000 of this total.
  • Eighteen of the countries in the region saw an increase in cases and 16 saw decreases.
  • Mexico had the second-highest number of new cases with a 60% increase (21,767 new cases), with 117 new deaths (12% decrease).
Vaccines
  • From the first COVID-19 vaccine on Dec. 8, 2020 to June 9, 2022, more than 11.9 billion vaccine doses have been administered in an effort to fight the pandemic; currently at a rate of 11 million doses daily.
  • Across the globe, 20% of people who have received at least one vaccination are from North America or Europe and 22% are from high-income countries. The wealthiest 50 countries have just 16.7% of the world’s population but have 21.5% of the vaccines. In the U.S. this works out to 4.9% of the vaccines but only 4.3% of the global population. To look at the flip side, the least wealthy 50 countries have 8.5% of the vaccine and 20.6% of the population.
  • The U.S. vaccination rate is 169,008 doses a day, a dramatic decrease from previous weeks. According to the CDC, 258.9 million people (or 78%) in the U.S. have received at least one dose of a COVID-19 vaccine. Of those, 221.6 million people (or 66.7%) have been fully vaccinated. More than 104.1 million people have received an additional booster shot since approval on Aug. 13, with about 1.2 million receiving boosters before they were approved. Many people are eligible for a second booster, and 15.05 million second boosters have been given.
  • According to the New York Times, “There are many reasons eligible people are not vaccinated or boosted. Surveys have indicated that some people are adamant in their refusal of the coronavirus vaccines, while others are open to getting a shot but have been putting it off or want to wait and see before making a decision for themselves or for their children. The first group, surveys have shown, tends to be disproportionately white, rural, evangelical Christian and Republican. The second group tends to be a more diverse and urban group, including many younger people, Black and Latino residents, and Democrats.”
  • The New York Times is tracking vaccine distribution on a state-by-state basis within the U.S. See the Vaccine Tracker for more information about vaccine development and the stages of different vaccines under development.
Variants

The CDC has four levels of classifications for variants: Variants Being Monitored (VBM), Variants of Interest (VOI), Variants of Concern (VOC) and Variants of Consequence (VOHC). Currently, there are 11 variants being monitored, one variant of concern – Omicron including its variants (B.1.1.529, BA.1, BA.1.1, BA.2, BA.3, BA.4 and BA.5 lineages) – and no VOIs or VOHC.

For the week ending June 11, the majority of cases in the U.S. came from an Omicron sub-variant BA.2.12.1 (64.2%) with 14.2% caused by BA.2, 13.3% from BA.5, and 8.3% from BA.4. The increase in BA.4 and BA.5 infections is troubling, with the Biden administration predicting up to 100 million new cases in the fall and winter.

New York Magazine reports, “There is also reason to worry that the current wave may not subside for a long time, particularly now that the two newest and most troubling Omicron subvariants, BA.4 and BA.5, may be starting to outcompete their predecessors. While previous nationwide surges in cases have mostly played out as single waves, this new one might be more like a flood. It could plateau, or dip and swell from that higher baseline across the coming weeks or even months.”

WHO is tracking one VOCs (Omicron B.1.1.529 and its lineages BA.1, BA.2, BA.3, BA.4, BA.5 and descendent lineages) and no VOIs or Variants Under Monitoring (VUMs). WHO has created a new category – VOC lineages under monitoring (VOC-LUM). There are six VOC-LUMs that are all Omicron variants: BA.4, BA.5, BA.2.12.1, BA.2.9.1, BA.2.11, and BA.2.13.

As of June 1, the WHO said: “The Omicron VOC remains the dominant variant circulating globally, accounting for nearly all sequences reported. Among the Omicron sublineages, BA.2 is the dominant sublineage, despite declining from 78% to 75% of Omicron sequences submitted in the last 30 days. The BA.1 sublineage has also declined in prevalence from 7% to 4%. Three Omicron sublineages have shown an increasing trend among Omicron sequences submitted in the last 30 days: BA.2.12.1 has risen from 11% to 16%; BA.4 has risen from 2% to 3%; and BA.5 has risen from 1% to 2%. During the same period, the prevalence of BA.3 has declined to <1%.”

As this disease continues to spread across the world and emerge in new countries, despite the implementation of vaccines, the needs of communities and responding NGOs, governments and medical facilities are becoming clearer. As the pandemic continues into its second year, some key areas still need attention, although these vary depending upon the stage of the pandemic in a particular community. There is a distinct split internationally and domestically in terms of needs and a split between higher-income and lower-middle-income countries, on a global level.

Unrestricted access to timely and accurate information.

Many people around the world do not have accurate information about COVID-19 because they may not have access to it or the information may only be available through a gatekeeper. Even when they do have access, the information may be out of date or not factually correct. People have the right to unrestricted access to accurate and timely information so that they can make informed decisions about their health.

Vaccine support

There are significant concerns about the equitable distribution of vaccines both in the U.S. and around the world. On an international level, this means supporting the production and distribution of vaccines (see data on vaccine distribution inequities above), while on a domestic level it is focused more on education and supporting targeted distribution. As the focus of vaccine support moves to lower- and middle-income countries, supporting a strong health system will be critically important.

Income, basic needs and livelihoods

This continues to be a critical need. Research about COVID-19’s impact on poverty is mixed. Prior to the pandemic, about 34 million Americans, 10.5% of the population, lived in poverty. While this had been decreasing (2018’s rate was 11.5% and it was 14.8% in 2014), 2020 saw the largest annual increase since the 1960s.

Eight million people fell into poverty in 2020 increasing the rate to 11.8% in December 2020. While there was some temporary relief following a trillion-dollar investment in social programs these are already rolling back. The rates of poverty are even more extreme internationally, both before and after the pandemic started. In 2019, 8.2% of the world’s population lived on less than $1.90 a day (the threshold for extreme poverty). While this is an incredible reduction from the 1960s when 80% of the world’s population lived in extreme poverty, the pandemic has set back decades of declining poverty rates.

It was already unlikely that the world would achieve its sustainable development goal of eliminating poverty by 2030, despite the great progress to date. COVID-19 reversed the decline and has added an estimated 124 million more people into extreme poverty.

In the U.S. as businesses reopened, they struggled to find workers due to low wages, lack of child care or fear of exposure to COVID-19 for frontline workers, especially those who are unvaccinated. In all countries, a large percentage of people are daily wage workers who are struggling due to quarantines, reduced incomes of their customers and decreased tourism. This has affected women more than men, across the globe. Supports are needed to provide economic opportunities through both direct cash giving and supporting employment including entrepreneurial options.

Mental health issues and suicide

Serious mental health needs have emerged throughout the pandemic. During a CDP webinar on support for mental health, bereavement and grief Huong Diep, a consulting psychologist with the Headington Institute said, “There are no safety zones anymore. All of us are simultaneously experiencing and grieving during this disaster, therefore our emotional bandwidths are stressed and limited.”

Intimate partner violence/Child abuse/Trafficking

There are also increased reports of Intimate Partner Violence (IPV) and child abuse. In both instances, many people are required to spend more time with their abusers. Those who work in these areas have also reported to CDP staff concerns about human trafficking, especially of young girls being sold by their families and young women being trafficked across borders.

Children and youth

The needs of children and youth include access to education, as well as concerns about mental health, digital literacy, foster care, immigration and abuse. Family poverty is also a concern as it impacts basic needs around access to housing, food, medical care, etc. Programs to provide additional support to children and their families are critical in all of these areas.

Medical needs

While the U.S. has been getting a much better handle on PPE, respirators, medical staffing, etc., however, each surge has created challenges in this area. PPE and medical support continue to be an extreme challenge internationally as new hot spots emerge.

In the U.S., many hospitals do not have enough staff to meet demand. Many international NGOs working in multiple countries have told CDP staff that respirators, oxygen and PPE are in extremely short supply. Additionally, they have indicated that very little testing is being done due to a lack of equipment or labs and therefore numbers being reported are severe undercounts, especially in low and middle-income countries.

Medical needs also continue to be a concern in terms of access to healthcare and prevalence of pre-existing health conditions. Support in this area includes provision of medical equipment, supplies and medication, and supporting the deployment of emergency health teams to areas needing support.

Long COVID

Maria DeJoseph Van Kerkhove, an infectious disease epidemiologist working at the WHO, says that 2-3 people are likely to develop long COVID symptoms for every 10 people who develop COVID-19.

Long COVID is an area of the disease that requires more research, as well as support for those individuals who contract it.

CDP has a COVID-19 Response Fund that provides an opportunity for donors to meet the ongoing and ever-expanding challenges presented by this virus. As of October 2021, CDP has granted more than $32.7 million to more than 150 organizations working in the U.S. and abroad, including grants made to fund projects in collaboration with other CDP funds.

Support recovery now

Contact CDP

Philanthropic contributions

If you would like to make a donation to the CDP COVID-19 Response Fund, please contact development.

(Photo: Syrian American Medical Society (SAMS) distributes hygiene kits in the Beka’a Valley in Lebanon to assist refugees with personal protection and household sanitization. Source: SAMS)

Recovery updates

If you are a responding NGO or a donor, please send updates on how you are working in this crisis to Tanya Gulliver-Garcia.

We welcome the republication of our content. Please credit the Center for Disaster Philanthropy.

Donor recommendations

If you are a donor looking for recommendations on how to help in this crisis, please email Regine A. Webster.

Note: If you are an individual within the U.S. affected by this disaster, we encourage you to call your local 211 to see what resources are available in your community or look at the 2-1-1 COVID-19 Resources Page.

More ways to help

Plan your giving in response to COVID-19. Do not just react to the latest media report. Research the facts and the organizations that are responding. There is a lot of misinformation being circulated. The WHO and the CDC COVID-19 websites are recommended sources of timely, reliable information. CDP works to stay updated on who is responding and is happy to discuss needs with responding funders.

There are going to be multiple phases and needs in this crisis – the medical response situation, support for research and assisting vulnerable people who have been impacted. Match your giving to one of these areas or decide how you will transition funds as needs change. You may want to allocate your giving in a few ways:

  1. Give to Funds: Not everyone is an expert or has time to invest in researching the many organizations that are responding to the COVID-19 pandemic. By donating to a fund, you can pool your donation with other donors to have a more impact. Let the grants management experts conduct the research and due diligence to find the best organizations. In addition to our own COVID-19 Response Fund, CDP is aware of many large international funds or funds responding on a broad level. Funders should also consider specialized intermediary funds that are tackling key issues. Intermediary funds can allow donors to provide a grant that will be divided into multiple, smaller grants to support grassroots, frontline organizing or service delivery within organizations that may not have the capacity to receive a large grant.
  2. Fund local NGOs: As with all disasters, this epidemic is going to start and end locally. Think about the local NGOs that you already support in the areas of housing/homelessness, healthcare, nutrition/food support, mental health, domestic violence, care for seniors etc. There is going to be an increased need for their services during and after this outbreak. They need flexible, unrestricted funds that can provide additional dollars to deal with this epidemic. This is critical on an international level to develop or support the ongoing capacity of those organizations that will remain after international agencies leave.
  3. Expand existing giving: Be innovative in supporting your grantees. Reach out to your existing grantees to see how the crisis has affected them. Consider issuing additional funding to help them meet the latest needs of their clients. Or change their reporting requirements, deadlines and expectations to allow them to redirect funds.
  4. Partner with other funders: Our friends at the Communities Foundation of Texas shared that 20 funders and local United Ways in North Texas have created a funder collaborative called North Texas Cares with a joint application form and system. Funders can fund independently or pool funds, but NGOs need to only complete an application once.

CDP has also created a list of suggestions for foundations to consider related to disaster giving.

Related resources

See them all

Pandemics and Infectious Diseases

Pandemics and Infectious Diseases

A pandemic is the sustained transmission of an infectious disease across a wide area of one country or across international borders. Pandemics may be either naturally occurring or the result of human intervention through genetic engineering or biological warfare.